#ASGCT
#ASGCT
#ASGCT
#ASGCT
#ASGCT
#ASGCT
#MTMCD
#MTMCD
#MTNA #ASGCT
#MTNA #ASGCT
http://dlvr.it/TM2Ln3
http://dlvr.it/TM2Ln3
Topics: Cell therapy for AML and Updates on rare pediatric cancer
Date/time: August 6, 2025 at 1 PM CT
http://dlvr.it/TLrm7S
Topics: Cell therapy for AML and Updates on rare pediatric cancer
Date/time: August 6, 2025 at 1 PM CT
http://dlvr.it/TLrm7S
http://dlvr.it/TLJ8g7
http://dlvr.it/TLJ8g7
http://dlvr.it/TLHsX4
http://dlvr.it/TLHsX4
http://dlvr.it/TLH7C8
http://dlvr.it/TLH7C8
#MolecularTherapy #NucleicAcids
#MolecularTherapy #NucleicAcids
http://dlvr.it/TK4psC
#CancerTherapy #CancerResearch
http://dlvr.it/TK4psC
#CancerTherapy #CancerResearch
#MolecularTherapy #FreeWebinar #GeneTherapy #CellTherapy #ASGCT
#MolecularTherapy #FreeWebinar #GeneTherapy #CellTherapy #ASGCT
In this episode, Drs. Aysegül Yildiz and Tim Beissert join #MTNA's Editor-in-Chief Paloma Giangrande to discuss their recent MTNA article on trans-amplifying RNA expressing functional miRNA.
Listen + subscribe! bit.ly/4brE76a
In this episode, Drs. Aysegül Yildiz and Tim Beissert join #MTNA's Editor-in-Chief Paloma Giangrande to discuss their recent MTNA article on trans-amplifying RNA expressing functional miRNA.
Listen + subscribe! bit.ly/4brE76a
In this new video, join @asgct.bsky.social + @moltherapy.bsky.social leaders who discuss how our prestigious publications have shaped the landscape of
#genetherapy and #celltherapy research for the past 25 years. youtu.be/hYPFoVlxqZQ
In this new video, join @asgct.bsky.social + @moltherapy.bsky.social leaders who discuss how our prestigious publications have shaped the landscape of
#genetherapy and #celltherapy research for the past 25 years. youtu.be/hYPFoVlxqZQ